Skip to main content
SpringerLink
Log in

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer: World Experience

  • Chapter
Intraperitoneal Cancer Therapy

Part of the book series: Current Clinical Oncology ((CCO))

Abstract

Research into the incorporation of hyperthermic intraperitoneal chemotherapy into treatment regimens for women with ovarian carcinoma has lagged behind that of other cancers causing peritoneal carcinomatosis despite the fact that ovarian cancer represents an excellent target for this modality of treatment. This chapter reviews experience with this technique from around the world, with the exception of France, and discusses future developments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Spratt JS, Adcock RA, Muskovin M, et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40(2):256–260.

    PubMed  CAS  Google Scholar 

  2. Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997;79(5):884–891.

    Article  PubMed  CAS  Google Scholar 

  3. Witkamp AJ, de Bree E, Kaag MM, et al. Extensive cytoreductive surgery followed by intraoperative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001;37(8):979–984.

    Article  PubMed  CAS  Google Scholar 

  4. Loggie BW, Fleming RA, McQuellon RP, et al. Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg 2001;67(10):999–1003.

    PubMed  CAS  Google Scholar 

  5. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727–731.

    Article  PubMed  CAS  Google Scholar 

  6. Alberts DS, Green S, Hannigan EV, et al. Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer [erratum appears in J Clin Oncol 1992;10(9):1505]. J Clin Oncol 1992;10(5):706–177.

    PubMed  CAS  Google Scholar 

  7. McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). Semin Oncol 1996;23(5 Suppl 12):40–47.

    PubMed  CAS  Google Scholar 

  8. Muggia FM, Braly PS, Brady MF, et al. Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study [see comment]. J Clin Oncol 2000;18(1):106–115.

    PubMed  CAS  Google Scholar 

  9. Ozols RF, Bundy BN, Greer BE, et al. Gynecologic Oncology G. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2003;21(17):3194–3200.

    Article  PubMed  CAS  Google Scholar 

  10. Alberts DS, Liu PY, Hannigan EV, et al. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Eng J Med 1996;335(26):1950–1955.

    Article  CAS  Google Scholar 

  11. Markman M, Bundy BN, Alberts DS, et al. Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 2001;19(4):1001–1007.

    PubMed  CAS  Google Scholar 

  12. Armstrong DK, Bundy BN, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Eng J Med 2006;354:34–43.

    Article  CAS  Google Scholar 

  13. Jaaback K. Johnson N. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2006;(1):CD005340.

    Google Scholar 

  14. Giovanella BC, Stehlin JS, Jr., Morgan AC. Selective lethal effect of supranormal temperatures on human neoplastic cells. Cancer Res 1976;36(11 Pt 1):3944–3950.

    PubMed  CAS  Google Scholar 

  15. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res 1979;39(6 Pt 2):2264–2268.

    PubMed  CAS  Google Scholar 

  16. Meyn RE, Corry PM, Fletcher SE, et al. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Res 1980;40(4):1136–1139.

    PubMed  CAS  Google Scholar 

  17. Alberts DS, Peng YM, Chen HS, et al. Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. J Natl Cancer Inst 1980;65(2):455–461.

    PubMed  CAS  Google Scholar 

  18. Los G, van Vugt MJ, Pinedo HM. Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 1994;69(2):235–241.

    PubMed  CAS  Google Scholar 

  19. Akaboshi M, Tanaka Y, Kawai K, et al. Effect of hyperthermia on the number of platinum atoms binding to DNA of HeLa cells treated with 195mPt-radiolabelled cis-diaminedichlor oplatinum(II). Int J Radiat Biol 1994;66(2):215–220.

    Article  PubMed  CAS  Google Scholar 

  20. Herman TS, Teicher BA, Cathcart KN, et al. Effect of hyperthermia on cis-diamminedichlo roplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline. Cancer Res 1988;48(18):5101–5105.

    PubMed  CAS  Google Scholar 

  21. van de Vaart PJ, van der Vange N, Zoetmulder FA, et al. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer 1998;34(1):148–154.

    Article  PubMed  Google Scholar 

  22. Loggie BW, Sterchi JM, Rogers AT, et al. Intraperitoneal hyperthermic chemotherapy for advanced gastrointestinal and ovarian cancers. Reg Cancer Treat 1994;2:78–81.

    Google Scholar 

  23. Steller MA, Egorin MJ, Trimble EL, et al. A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with smallvolume residual ovarian cancer [erratum appears in Cancer Chemother Pharmacol 1999;44(1):90]. Cancer Chemother Pharmacol 1999;43(2):106–114.

    Article  PubMed  CAS  Google Scholar 

  24. van der Vange N, van Goethem AR, Zoetmulder FA, et al. Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot. Eur J Surg Oncol 2000;26(7):663–668.

    Article  PubMed  Google Scholar 

  25. Cavaliere F, Perri P, Di Filippo F, et al. Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 2000;74(1):41–44.

    Article  PubMed  CAS  Google Scholar 

  26. Deraco M, Rossi CR, Pennacchioli E, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumor 2001;87:120–126.

    CAS  Google Scholar 

  27. Panteix G, Beaujard A, Garbit F, et al. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy. Anticancer Res 2002;22(2B):1329–1336.

    PubMed  CAS  Google Scholar 

  28. Ajisaka H, Yonemura Y, Bando E, et al. Long-term survival of a patient with primary papillary serous carcinoma of the peritoneum treated by subtotal peritonectomy plus intraoperative chemohyperthermia. Hepatogastroenterology 2002;49(46):1027–1029.

    PubMed  Google Scholar 

  29. de Bree E, Romanos J, Michalakis J, et al. Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin. Anticancer Res 2003;23(3C):3019–3027.

    PubMed  Google Scholar 

  30. Zanon C, Clara R, Chiappino I, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg 2004;28(10):1040–1045.

    Article  PubMed  Google Scholar 

  31. Look M, Chang D, Sugarbaker PH. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 2004;14(1):35–41.

    Article  PubMed  CAS  Google Scholar 

  32. Piso P, Dahlke M-H, Loss M, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer. World J Surg Oncol 2004;2:21–27.

    Article  PubMed  Google Scholar 

  33. Ryu KS, Kim JH, Ko HS, et al. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol 2004;94(2):325–332.

    Article  PubMed  CAS  Google Scholar 

  34. Gori J, Castano R, Toziano M, et al. Intraperitoneal hyperthermic chemotherapy in ovarian cancer. Int J Gynecol Cancer 2005;15(2):233–239.

    Article  PubMed  CAS  Google Scholar 

  35. Reichman TW, Cracchiolo B, Sama J, et al. Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma. J Surg Oncol 2005;90(2):51–56.

    Article  PubMed  Google Scholar 

  36. Yoshida Y, Sasaki H, Kurokawa T, et al. Efficacy of intraperitoneal continuous hyperthermic chemotherapy as consolidation therapy in patients with advanced epithelial ovarian cancer: a long-term follow-up. Oncol Rep 2005;13(1):121–125.

    PubMed  CAS  Google Scholar 

  37. Helm CW, Randall-Whitis L, Martin III, RS, Metzinger DS, Gordinier ME, Parker LP, Edwards RP. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma. Gynecol Oncol 2007;105(1):90–96.

    Article  PubMed  CAS  Google Scholar 

  38. Munkarah AR, Coleman RL. Critical evaluation of secondary cytoreduction in recurrent ovarian cancer. Gynecol Oncol 2004;95:273–280.

    Article  PubMed  CAS  Google Scholar 

  39. Rubin SC, Randall TC, Armstrong KA, et al. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstet Gynecol 1999;93(1):21–24.

    Article  PubMed  CAS  Google Scholar 

  40. Chang E, Alexander HR, Libutti SK, et al. Laparoscopic continuous hyperthermic peritoneal perfusion. J Am Coll Surg 2001;193(2):225–229.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics, Gynecology, and Women’s Health, Division of Gynecologic Oncology, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY

    C. William Helm MA, MB BChir, FRCS

Authors
  1. C. William Helm MA, MB BChir, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics, Gynecology, and Women’s Health, Division of Gynecologic Oncology, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY

    C. William Helm MA, MB BChir, FRCS

  2. University of Pittsburgh School of Medicine, Pittsburgh, PA

    Robert P. Edwards MD (Vice Chairman of Clinical Affairs, Director, Ovarian Cancer Center of Excellence, Professor of Obstetrics, Gynecology, and Reproductive Sciences) (Vice Chairman of Clinical Affairs, Director, Ovarian Cancer Center of Excellence, Professor of Obstetrics, Gynecology, and Reproductive Sciences)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Helm, C.W. (2007). Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer: World Experience. In: Helm, C.W., Edwards, R.P. (eds) Intraperitoneal Cancer Therapy. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59745-195-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-195-6_10

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-878-2

  • Online ISBN: 978-1-59745-195-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation